Connect with us
AseBio presented its 2025 report on the Biotech Act, highlighting opportunities for Spanish biotechnology while urging greater ambition, funding, and implementation. Spain’s biotech sector shows strong...
New biomarkers and targeted therapies are reshaping the management of kidney damage in autoimmune diseases like lupus and vasculitis. Experts at a Spanish medical meeting highlighted...
EFPIA supports the EU Biotechnology Law and a 12-month SPC extension but warns the current proposal is too limited. A broader scope could attract up to...
German biotech held steady in 2025 but faces ongoing financing pressures, according to EY-Parthenon and BIO Deutschland. Total capital fell 5% to €1.8 billion, with venture...
TG Therapeutics reported strong Phase 1 results for subcutaneous Briumvi in multiple sclerosis, exceeding expectations in bioavailability, safety, and tolerability. The formulation could significantly expand its...
Type 2 diabetes is strongly linked to obesity, and early, strict control may improve outcomes for millions of patients. The SURPASS-EARLY study shows tirzepatide outperforms standard...
Molecular Health GmbH, a Heidelberg-based biotech firm, filed for insolvency on June 1st, 2026, under self-administration. An investor consortium will take over its core business, continuing...
Argentina is advancing local flu vaccine production through an agreement between Sinergium Biotech, CSL Seqirus, and PAHO, boosting regional supply across Latin America and the Caribbean....
The European Commission’s draft Biotech Law II has drawn input from alternative protein and industrial biotech firms seeking clearer rules for fermentation, cultured biomass, and precision...
AstraZeneca will present over 85 abstracts at ASCO 2026, showcasing late-stage data across multiple cancers and a rare hematological disease. Highlights include trials in liver, breast,...
 |
|
 |  |
 |
|